Home
Home » companies

Roche

Drugmakers 'could free $33 bln of working capital'-analysts

Drugmakers 'could free $33 bln of working capital'-analysts
Reuters

AstraZeneca: Will New Drugs And CEO Reward Investors?

AstraZeneca: Will New Drugs And CEO Reward Investors?
Seeking Alpha

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say

Lung Cancer Genomic Mapping Yields New Targets, Researchers Say
Bloomberg

Roche expects to keep Rituxan monopoly until 2015

Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma

Roche ramps up Alzheimer's drug trial as rivals stumble

Roche ramps up Alzheimer's drug trial as rivals stumble
Yahoo/Reuters

Roche Hosts An Encouraging Investor Day

Roche Hosts An Encouraging Investor Day
Seeking Alpha

Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies

Roche Vows To Keep Up R&D Spend, Go Beyond Cancer Therapies
NASDAQ.com

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib

This Drug Is Getting Some Negative ATTENTION: ArQule's Tivantinib
Motley Fool

Big Pharma betting billions in high-stakes hunt for the next Lipitor

Big Pharma betting billions in high-stakes hunt for the next Lipitor
Fierce Biotech

ImmunoGen Rises On Partner Roche’s Results

ImmunoGen Rises On Partner Roche’s Results
Bloomberg